Publication | Closed Access
A randomised double-blind phase II study of lamivudine (LAM) compared to lamivudine plus adefovir dipovoxil (ADV) for treatment naïve patients with chronic hepatitis B (CHB): Week 52 analysis
82
Citations
0
References
2003
Year
HepatologyViral HepatitisMedicineHepatitis BHepatitisAntiviral TherapyChronic Hepatitis BPharmacotherapyLiver DiseasePharmacologyTreatment Naïve Patients
No additional data available for this publication yet. Check back later!